Index removals put Cabot in focus for benchmarked investors

Cabot (CBT) has been removed from several Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth benchmarks, a shift that can trigger portfolio adjustments for index-tracking funds.

Cabot's removal from multiple Russell growth indices comes at a time when its share price has a 30 day share price return of 6.73% and a year to date share price return of 39.30%, while the 1 year total shareholder return is 25.13%. This suggests recent momentum has been strong compared with longer term performance.

If this kind of index related move has you looking beyond a single specialty chemicals stock, it can be a good moment to see which other companies stand out in the market using the 20 top founder-led companies

Cabot now trades around $93.40, close to a consensus price target of $88.50 and with recent returns well ahead of its longer term record. This raises the key question: is there still value on the table, or is the market already pricing in future growth?

Most Popular Narrative: 5.5% Overvalued

Cabot's most followed narrative puts fair value at $88.50, a little below the last close at $93.40, which frames the recent index related moves in valuation terms.

Battery Materials is growing quickly, supported by 43% year over year revenue growth and trailing 12 month EBITDA margins of about 24%. If this high margin, higher growth part of Cabot continues to scale while the market prices the business on more of a specialty materials profile, the share price could trend higher instead of staying flat as earnings and cash flow expand.

Want to see what is baked into that $88.50 fair value for Cabot? Revenue assumptions, margin rebuild and a reset future earnings multiple all sit at the core.

Result: Fair Value of $88.50 (OVERVALUED)

However, there is still a risk that weaker carbon black fundamentals and slower recognition of Cabot's Performance Chemicals potential could limit how quickly this narrative plays out.

Another View: How Cabot Looks On Earnings Multiples

The fair value narrative for Cabot centers on $88.50 per share, slightly below the current $93.40. Yet on simple earnings multiples, Cabot trades on a P/E of 17.2x, below both its peer average of 29.7x and an estimated fair ratio of 21.7x. That kind of gap can signal either valuation support or a sign the market is pricing in real risks. Which side of that trade do you think you are on?

To see how this earnings based view stacks up against a fuller valuation breakdown, including the fair ratio and peer comparison, take a closer look at the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With Cabot's mixed signals on valuation and index status, are you comfortable with the current balance of upside and downside, or does it leave you questioning the market's stance? If you want to weigh both the concerns and the potential upside for yourself, start by reviewing the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Cabot?

If Cabot's story has you thinking about where else capital could work harder, it is worth lining up a few fresh ideas before the next move.

• Target potential mispricings by scanning for companies that combine quality fundamentals with appealing valuations using the 44 high quality undervalued stocks
• Prioritize resilience by focusing on companies with stronger finances through the solid balance sheet and fundamentals stocks screener (48 results)
• Hunt for lesser known opportunities that still meet clear quality hurdles with the screener containing 19 high quality undiscovered gems

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.